109 related articles for article (PubMed ID: 20129447)
1. [Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors].
Snanoudj R; Rabant M; Royal V; Pallet N; Noël LH; Legendre C
Nephrol Ther; 2009 Dec; 5 Suppl 6():S365-70. PubMed ID: 20129447
[TBL] [Abstract][Full Text] [Related]
2. [Monitoring of calcineurin inhibitors induced-nephrotoxicity].
Kamar N; Rostaing L
Nephrol Ther; 2008 Jun; 4 Suppl 1():S13-S17. PubMed ID: 18703392
[TBL] [Abstract][Full Text] [Related]
3. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease after nonrenal solid organ transplantation: a histological assessment and utility of chronic allograft damage index scoring.
Kubal C; Cockwell P; Gunson B; Jesky M; Hanvesakul R; Dronavalli V; Bonser RS; Neil D
Transplantation; 2012 Feb; 93(4):406-11. PubMed ID: 22217532
[TBL] [Abstract][Full Text] [Related]
5. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
Hesselink DA; Bouamar R; van Gelder T
Ther Drug Monit; 2010 Aug; 32(4):387-93. PubMed ID: 20571464
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
Issa N; Kukla A; Ibrahim HN
Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
[TBL] [Abstract][Full Text] [Related]
7. [Replacing calcineurin inhibitors with proliferation signal inhibitors after kidney transplantation: indications, results, and disadvantages].
Audard V
Nephrol Ther; 2009 Dec; 5 Suppl 6():S395-9. PubMed ID: 20129452
[TBL] [Abstract][Full Text] [Related]
8. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts.
Liptak P; Ivanyi B
Nat Clin Pract Nephrol; 2006 Jul; 2(7):398-404; quiz following 404. PubMed ID: 16932468
[TBL] [Abstract][Full Text] [Related]
9. [Review of clinical trials on minimization and interruption of calcineurin inhibitors (CNIs) and protocols without CNIs in the transplantation of different organs (kidney, heart, and liver)].
Albano L
Nephrol Ther; 2009 Dec; 5 Suppl 6():S371-8. PubMed ID: 20129448
[TBL] [Abstract][Full Text] [Related]
10. Chronic calcineurin inhibitor nephrotoxicity-lest we forget.
Chapman JR
Am J Transplant; 2011 Apr; 11(4):693-7. PubMed ID: 21446974
[TBL] [Abstract][Full Text] [Related]
11. Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkers.
Pallet N; Djamali A; Legendre C
Pharmacol Res; 2011 Jul; 64(1):25-30. PubMed ID: 21473913
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
Kushwaha SS; Khalpey Z; Frantz RP; Rodeheffer RJ; Clavell AL; Daly RC; McGregor CG; Edwards BS
J Heart Lung Transplant; 2005 Dec; 24(12):2129-36. PubMed ID: 16364861
[TBL] [Abstract][Full Text] [Related]
13. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
14. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
Gaston RS
Clin J Am Soc Nephrol; 2009 Dec; 4(12):2029-34. PubMed ID: 19850771
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
Guerra G; Srinivas TR; Meier-Kriesche HU
Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
[TBL] [Abstract][Full Text] [Related]
16. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
[TBL] [Abstract][Full Text] [Related]
17. [Proliferation signal inhibitors: what therapeutic protocols are followed in 2009?].
Ladrière M
Nephrol Ther; 2009 Dec; 5 Suppl 6():S385-9. PubMed ID: 20129450
[TBL] [Abstract][Full Text] [Related]
18. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
[TBL] [Abstract][Full Text] [Related]
19. [Calcineurin inhibitors minimisation and anti-proliferative strategies].
Pascual J
Nephrol Ther; 2008 Jun; 4 Suppl 1():S29-S35. PubMed ID: 18703395
[TBL] [Abstract][Full Text] [Related]
20. Specificity of histological markers of long-term CNI nephrotoxicity in kidney-transplant recipients under low-dose cyclosporine therapy.
Snanoudj R; Royal V; Elie C; Rabant M; Girardin C; Morelon E; Kreis H; Fournet JC; Noël LH; Legendre C
Am J Transplant; 2011 Dec; 11(12):2635-46. PubMed ID: 21883915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
